Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Peijia Medical Ltd. (9996) Stock Price & Analysis

2 Followers

9996 Stock Chart & Stats

HK$3.96HK$0.23(6.31%)
At close: 4:00 PM GMT+8
HK$4HK$5Aug 10Aug 24Sep 7Sep 21Oct 5Oct 20Nov 2
Day’s Range
HKD 3.79 - HKD 4.00
52-Week Range
HKD 3.55 - HKD 7.37
Previous Close
HKD 3.73
Volume
N/A
Average Volume (3M)
651.93K
Market Cap
HKD 2.52B
Enterprise Value
HKD 2.46B
Total Cash (Recent Filing)
HKD 761.12M
Total Debt (Recent Filing)
HKD 652.57M
Price to Earnings (P/E)
―
Beta
1.04
Next Earnings
Apr 01, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Gross Margin

A gross margin near 67% indicates the company retains substantial value from each sale before operating costs. This provides a durable base for funding research, commercialization, and market expansion, while offering potential operating leverage if revenue grows faster than expenses.

Revenue Scale-Up

Meaningful multi-year revenue expansion shows that Peijia has progressed beyond an early commercial stage and is building demand for its medical-device portfolio. Continued revenue development can improve fixed-cost absorption and create a broader base from which profitability may eventually emerge.

Manageable Leverage

Low debt relative to equity gives the company more financial flexibility than a highly leveraged structure would provide. This capitalization can help Peijia continue investing in product development and commercialization while reducing the immediate burden of debt service during its loss-making period.

Bears Say

Persistent Operating Losses

Persistent operating and net losses show that the current business model has not yet converted revenue and gross profit into sustainable earnings. Until expenses are better absorbed or margins improve below the gross-profit line, growth may continue without establishing durable shareholder returns.

Negative Cash Generation

Ongoing negative operating and free cash flow means the company is consuming cash even as revenue scales. This can increase reliance on external funding, constrain investment choices, and make the path to self-financing uncertain until profitability and cash conversion improve.

Negative Returns On Equity

Negative ROE indicates that the capital invested in the business is not currently generating a positive accounting return. If losses persist, retained capital may produce limited shareholder value and could gradually weaken the company’s financial base despite currently manageable leverage.

Peijia Medical Ltd. News

9996 FAQ

What was Peijia Medical Ltd.’s price range in the past 12 months?
Peijia Medical Ltd. lowest stock price was HK$3.55 and its highest was HK$7.37 in the past 12 months.
What is Peijia Medical Ltd.’s market cap?
Peijia Medical Ltd.’s market cap is HK$2.52B.
When is Peijia Medical Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Peijia Medical Ltd.’s earnings last quarter?
Peijia Medical Ltd. released its earnings results on Aug 21, 2026. The company reported -HK$0.012 earnings per share for the quarter.
Is Peijia Medical Ltd. overvalued?
According to Wall Street analysts Peijia Medical Ltd.’s price is currently Undervalued.
Does Peijia Medical Ltd. pay dividends?
Peijia Medical Ltd. does not currently pay dividends.
What is Peijia Medical Ltd.’s EPS estimate?
Peijia Medical Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Peijia Medical Ltd. have?
Peijia Medical Ltd. has 676,961,900 shares outstanding.
What happened to Peijia Medical Ltd.’s price movement after its last earnings report?
Peijia Medical Ltd. reported an EPS of -HK$0.012 in its last earnings report. Following the earnings report the stock price went down -1.68%.
Which hedge fund is a major shareholder of Peijia Medical Ltd.?
Currently, no hedge funds are holding shares in HK:9996
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology